Immunovant, Inc. Share Price & Technical Analysis
IMVT · $33.77 (-1.11%)
Healthcare / Biotechnology
$33.77
-1.11%
Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating po…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
26% return in May, 4% avg return in past 3 year May month.
34% return in 2026, 28% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 2% | 7% | -8% | 8% | 26% | – | – | – | – | – | – | – | 34% |
| 25 | -13% | -3% | -15% | -6% | -7% | 8% | 1% | -7% | 9% | 53% | -1% | 5% | 24% |
| 24 | -12% | -2% | -9% | -14% | -7% | 5% | 10% | 7% | -8% | 3% | -4% | -12% | -44% |
| 23 | -2% | -1% | -11% | 5% | 27% | -10% | 21% | 0% | 68% | -15% | 18% | 7% | 105% |
| 22 | -19% | -21% | -2% | -18% | -9% | -7% | 5% | 27% | 10% | 96% | 16% | 36% | 115% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Strong
Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$5.71B
P/E ratio
—
52W high
$36.28
52W low
$13.79
Volume
13,50,453
Beta
0.70
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Immunovant, Inc. share price today?
- Immunovant, Inc. (IMVT) last traded around $33.77 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does IMVT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for IMVT. Download the app for real-time alerts.
- How can I analyze Immunovant, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.